Skip to main content
SpringerLink
Log in

Vaccines Against Measles, Mumps, Rubella, and Varicella

  • Chapter
Vaccines

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 133))

Abstract

There are good reasons to draws parallels between the vaccines against the four diseases measles, mumps, rubella, and varicella. Each is a classical systemic childhood disease, and infection with wild-types of each of these viruses bequeaths a life-long protection upon renewed exposure to the infectious agent. Furthermore, live vaccines effectively preventing each of these tour diseases have been developed by empirical techniques. However, there are also important differences in pathogenic events connected with the acute diseases caused by these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Anderson RM, Crombie JA, Grenfell BT (1987) The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol Infect 99:65–84

    PubMed  CAS  Google Scholar 

  • Arbeter AM, Starr SE, Plotkin SA (1986) Varicella vaccine studies in healthy children and adults. Pediatrics 78:748–756

    PubMed  CAS  Google Scholar 

  • Asano Y, Suga S, Yoshikawa T, Kobayashi H, Yazaki T, Shibata M, Tsuzuki K, Ito S (1994) Experience and reason: twenty year follow up of protective immunity of the Oka live varicella vaccine. Pediatrics 94:524–526

    PubMed  CAS  Google Scholar 

  • Bellini WJ, Rota JS, Rota PA (1994) Virology of measles virus. J Infect Dis 170 [Suppl 1]:S15–S23

    PubMed  Google Scholar 

  • Berry S, Hernandez H, Kanashiro R, Campos M, Azabache V, Gomez G, Gutierrez M, Weirs B, de Quadros C, Halsey N (1992) Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccine in Peruvian Infants. Pediatr Infect Dis J 11:822–827

    PubMed  CAS  Google Scholar 

  • Best JM, Welch JM, Baker DA, Banatvala JE (1987) Maternal rubella at St Thomas’ Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet 2:88–90

    PubMed  CAS  Google Scholar 

  • Birrer MJ, Udem S, Nathenson S, Bloom BR (1981) Antigenic variants of measles virus. Nature 293:67–69

    PubMed  CAS  Google Scholar 

  • Black FL (1989) Measles active and passive immunity in a worldwide perspective. Prog Med Virol 36:1–33

    PubMed  CAS  Google Scholar 

  • Black FL, Sheridan SR (1967) Blood leukocyte response to live measles vaccine. Am J Dis Child 113:301–304

    PubMed  CAS  Google Scholar 

  • Böttiger M, Christenson B, Romanus V, Taranger J, Strandell A (1987) Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps and rubella. BMJ 295:1264–1267

    PubMed  Google Scholar 

  • Brinckman UG, Bankamp B, Reich A, ter Meulen V, Liebert UG (1991) Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. J Gen Virol 72:2491–2500

    Google Scholar 

  • Briss PA, Fehrs LJ, Parker RA, Wright PF, Sanella EC, Hutcheson RH, Schaffner W (1994) Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 169:77–82

    PubMed  CAS  Google Scholar 

  • Brown EG, Furesz J, Dimock K, Yarosh W, Contreras G (1991) Nucleotide sequence analysis of Urabe mumps vaccine that caused meningitis in vaccine recipients. Vaccine 9:840–842

    PubMed  CAS  Google Scholar 

  • Brunell PA, Novelli VM, Lipton SV, Pollock B (1988) Combined vaccine against measles, mumps, rubella and varicella. Pediatr 81:779–784

    CAS  Google Scholar 

  • Buynak EB, Hilleman MR (1966) Live attenuated mumps virus vaccine. I. Vaccine development. Proc Soc Biol Med 123:768–775

    CAS  Google Scholar 

  • Christenson B, Böttiger M (1994a) Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 12:41–45

    CAS  Google Scholar 

  • Christenson B, Böttiger M (1994b) Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects of the measles virus. Vaccine 12(2):129–133

    CAS  Google Scholar 

  • Cusi MG, Valosin PE, Cellesi C (1993) Possibility of reinfection after immunization with RA27/3 live attenuated ruella virus. Arch Virol 129:337–340

    PubMed  CAS  Google Scholar 

  • Cusi MG, Valassina M, Bianchi S, Wunner W, Valensin PE (1995) Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model. Virus Res 37:199–208

    PubMed  CAS  Google Scholar 

  • Cutts FT, Mandala K, St Louis M, Brown C, Mayala B, Zell ER, Deforest A, Kamenga M, Davachi F, Markowitz LE (1993) Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected in Kinshasa, Zaire. J Infect Dis 167:1418–1421

    PubMed  CAS  Google Scholar 

  • Davidkin I, Valle M, Julkunen I (1995) Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 13:1617–1622

    PubMed  CAS  Google Scholar 

  • Davis WJ, Larson HE, Simsarian JP, Parkman PD, Meyer HM (1971) A study of rubella immunity and resistance to infection. JAMA 215:600–608

    PubMed  CAS  Google Scholar 

  • Diaz-Ortega JL, Luna Abascal M, Valdesping JL, Sepulveda J, Markowitz LE, Zell ER (1992) Mortality and morbidity after high titre measles vaccine in Mexico. Lancet 340–924

    PubMed  CAS  Google Scholar 

  • Dorig RE, Marcil A, Chopra A, Richardson CD (1993) The human CD46 molecule is a receptor for meales virus (Edmonston strain). Cell 75:295–305

    PubMed  CAS  Google Scholar 

  • Dunster LM, Schneider-Schaulies J, Löffler S, Lankes W, Schwartz-Albiez R, Lottspeich F, ter Meulen V (1994) Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology 198:265–274

    PubMed  CAS  Google Scholar 

  • Dyken PR, Cunningham SC, Ward LC (1989) Changing character of subacute sclerosing panencephalitis in the United States. Pediatr Neurol 5:339–341

    PubMed  CAS  Google Scholar 

  • Edmonson MB, Addiss DG, Mcpherson JT, Berg JL, Circo SR, Davis JP (1990) Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2467–2471

    PubMed  CAS  Google Scholar 

  • Englund JA, Suarez CS, Kelly J, Tate DY, Balfour HH Jr (1989) Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine. J Pediatr 114:37–44

    PubMed  CAS  Google Scholar 

  • Ennis FA, Douglas RD, Hopps HE, Meyer HM Jr, Brown ER, Hobbins TE, Biehusen FC (1969) Clinical studies with virulent and attenuated mumps viruses. Am J Epidemiol 89:176–183

    PubMed  CAS  Google Scholar 

  • Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345:567–569

    PubMed  CAS  Google Scholar 

  • Feldman S, Hughes W, Daniel C (1975) Varicella in children with cancer: 77 cases. Pediatrics 80:388–397

    Google Scholar 

  • Fireman P, Friday G, Kumate J (1969) Effect of measles virus vaccine on immunological responsiveness. Peditarics 43:264–272

    CAS  Google Scholar 

  • Frenkel LM, Neilsen K, Garakian A, Wolinsky JF, Cherry JD (1996) A search for persistent rubella infection in persons with chronic symptoms after rubella and rubella immunization and in patient with juvenile rheumatoid arthritis. Clin Infect Dis 22:287–294

    PubMed  CAS  Google Scholar 

  • Frey TK (1994a) Molecular biology of rubella virus. Adv Virus Res 44:69–160

    CAS  Google Scholar 

  • Frey TK (1994b) Report of an international meeting on rubella vaccines and vaccination, 9 August 1993, Glasglow United Kingdom. J Infect Dis 70:507–509

    Google Scholar 

  • Garenne M, Leroy O, Beau J-P, Sene I (1991) Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 338:903–907

    PubMed  CAS  Google Scholar 

  • Gershon A (1995) Varicella-zoster virus: prospects for control. Adv Ped Infect Dis 10:93–124

    CAS  Google Scholar 

  • Gershon A, Steinberg S, Brunell P (1974) Zoster immune globulin: a further assessment. N Engl J Med 290:243–245

    PubMed  CAS  Google Scholar 

  • Gershon AA, Steinberg S, Gelb L, NIAID-Collaborative-Varicella-Vaccine-Study-Group (1984) Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 252:355–362

    PubMed  CAS  Google Scholar 

  • Giraudon P, Wild TF (1985) Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutinin inhibiting acvtivity. Virology 144:46–58

    PubMed  CAS  Google Scholar 

  • Giraudon P, Jacquier MF, Wild TF (1998) Antigenic analysis of African measles virus field isolates; identification and localisation of one conserved and two variable epitope sites on the NP protein. Virus Res 18:137–152

    Google Scholar 

  • Griffin DE, Bellini WJ (1996) Measles virus. In: Field BN, Knipe PM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Field virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1267–1312

    Google Scholar 

  • Guess H, Broughton D, Melton L, Kurland L (1985) Epidemiology of herpes-zoster in children and adolescents: a population-based study. Pediatrics 76:512-517

    PubMed  CAS  Google Scholar 

  • Gut JP, Lablache C, Behr S, Kirn A (1995) Symptomatic mumps virus reinfections. J Med Virol 45:17–23

    PubMed  CAS  Google Scholar 

  • Halloran E, Cochi S, Lieu T, Wharton M, Fehrs L (1994) Theoretical epidemiological and morbidity effects of routine immunization of preschool children with varicella vaccine in the United States. Am J Epidemiol 140:81–104

    PubMed  CAS  Google Scholar 

  • Halstead SB, Diwan AJ (1971) Failure to transmit rubella virus vaccine: a close-contact study in adults. JAMA 215:634–636

    PubMed  CAS  Google Scholar 

  • Hardy IB, Gershon A, Steinberg S, LaRussa P, the NIAID Collaborative varicella Vaccine Study Group (1991) The incidence Of zoster after Immunization with live attenuated varicella vaccine. A sudy in children with leukemia. N Engl J Med 325:1545–1550

    PubMed  CAS  Google Scholar 

  • Harmsen T, Jongerius MC, van der Zwan CV, Plantinga AD, Kraaijeveld CA, Berbers GAM (1992) Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of children vaccinated for mumps. J Clin Microbiol 30:2193–2144

    Google Scholar 

  • Hayden GC, Herrmann KL, Buimovici-Klein E (1980) Subclinical congenital rubella infection associated with maternal rubella vaccination in early pregnancy. J Pediatr 96:869–872

    PubMed  CAS  Google Scholar 

  • Hayward A, Villanueba E, Cosyns M, Levin M (1992) Varicella-zoster virus (VZV)- specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine. J Infects Dis 166:260–264

    CAS  Google Scholar 

  • Hersh BS, Fine PEM, Kent WK, Cochi SL, Kahn LH, Zell ER, Hays PL, Wood CL (1991) Mumps outbreak in a highly vaccinated population. J Pediatr 119:187–193

    PubMed  CAS  Google Scholar 

  • Hilleman MR (1992) Past, present and future of measles, mumps, and rubella virus vaccine. Pediatrics 90:149–153

    PubMed  CAS  Google Scholar 

  • Hilleman MR (1996) The development of live attenuated mumps virus vaccine in historic perspective and its role in the evolution of combined measles-mumps-rubella. In: Plotkin S, Fantini B (eds) Vaccinia, vaccination and vaccinology: Jenner, Pasteur and their successors. Elsevier, Paris, pp 283–292

    Google Scholar 

  • Holt A, Moulton LH, Siberry GK, Halsey NA (1993) Differential mortality by measles vaccine titer and sex. J Infect Dis 168:1087–1096

    PubMed  CAS  Google Scholar 

  • Howson CP, Fineberg HV (1992) Adverse events following pertussis and rubella vaccine. Summary of a report of the Institute of Medicine. JAMA 267:392–396

    PubMed  CAS  Google Scholar 

  • Institute of Medicine (1993) The Children’s Vaccine Initiative: achieving the vision. National Academy, Washington DC

    Google Scholar 

  • Job JS, Halsey NA, Boulos R, Holt E, Farrell D, Albrecht P, Brutus JR, Adrien M, Andre J Chan E, Kissinger P, Boulos C, Cité Soleil/JHU project team (1991) Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Pediatr Infect Dis 10:303–311

    CAS  Google Scholar 

  • Julkunen I, Vaananen P, Penttinen K (1984) Antibody responses to mumps virus proteins in natural mumps infection and after vaccination with live and inactivated mumps virus vaccines. J Med Virol 14:209–221

    PubMed  CAS  Google Scholar 

  • Khanum S, Garelick H, Uddin N, Mann G, Tomkins A (1987) Comparison of Edmonston-Zagreb and Schwarz of measles vaccine given by aerosol or subcutaneous injection. Lancet 1:150–153

    PubMed  CAS  Google Scholar 

  • Kobune F, Funatu M, Takahashi H, Fukushima M, Kawamoto A, Iizuka S, Sakata H, Yamazaki S, Arita M, Xu W, Li-Bi Z (1995) Characterization of measles virus isolated after measles vaccination. Vaccine 13:370–372

    PubMed  CAS  Google Scholar 

  • Krause P, Klinman DM (1995) Efficacy, immunogenicity, safety and use of live attenuated chickenpox vaccine. J Pediatr 127:518–525

    PubMed  CAS  Google Scholar 

  • Krugman S (1971) Present status of measles and rubella immunization in the United States: a medical progress report. J pediatr 78:1–16

    PubMed  CAS  Google Scholar 

  • Kunkel U, Driesel G, Henning U, Gerike E, Willers H, Schreier E (1995) Differentiation of vaccine and wild mumps viruses by polymerase chain reaction and nucleotide sequencing of the SH gene: brief report. J Med Virol 45:121–126

    PubMed  CAS  Google Scholar 

  • Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr S, Plotkin S (1991) Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 9:643–647

    PubMed  CAS  Google Scholar 

  • Lieu T, Cochi S, Black S, Halloran ME, Shinefield HR, Holmes SJ, Wharton M, Washington E (1994) Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 271:375–381

    PubMed  CAS  Google Scholar 

  • Massad E, Azevedo-Neto RS, Burattini MN, Zanetta DM, Coutrinho FA, Yang HM, Moraes JC, Pannuti CS, Souza VA, Silveira AS, Strouchiner CJ, Oselka GW, Camargo MCC, Omoto TM, Passos SD (1995) Assessing the efficacy of a mixed vaccination strategy against rubella in Sao Paulo, Brazil. Int J Epidemiol 24:842–850

    PubMed  CAS  Google Scholar 

  • Mathias RG, Meekison WG, Arcand TA (1989) The role of secondary vaccine failures in measles outbreaks. Am J Public Health 79:475–478

    PubMed  CAS  Google Scholar 

  • McAleer WJ, Markurs HZ, McLean AA, Buynak EB, Hilleman MR (1980) Stability on storage of various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. J Biol Stand 8:281–287

    PubMed  CAS  Google Scholar 

  • McDonald JC, Moore DL, Quennec P (1989) Clinical and epidemiological features of mumps meningoencephalitis and possible vaccine-related disease. Pediatr Infect Dis J 8:751–755

    PubMed  CAS  Google Scholar 

  • Mellinger Ak, Cragan JD, Atkinson WL, Williams WW, Kleger B, Kimber RG, Tavris D (1995) High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 14:573–578

    PubMed  CAS  Google Scholar 

  • Mellman WJ, Wetton R (1963) Depression of the tuberculin reaction by attenuated measles virus vaccine. J Lab Clin Med 61:453–458

    PubMed  CAS  Google Scholar 

  • Miller CL (1991) Rubella in the developing world. Epidemiol Infect 107:63–68

    PubMed  CAS  Google Scholar 

  • Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L, Tettmar R (1993) Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 341:979–982

    PubMed  CAS  Google Scholar 

  • Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M (1995) Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 13:799–802

    PubMed  CAS  Google Scholar 

  • Mitchell LA, Tingle AJ, Shukin R, Sangeorgan JA, McCune J, Braun DK (1993) Chronic rubella vaccine-associated arthropathy. Arch Intern Med 153:2268–2274

    PubMed  CAS  Google Scholar 

  • Monafo WJ, Haslam DB, Roberts RL, Zaki SR, Bellini WJ, Coffin CM (1994) Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr 124:273–276

    PubMed  CAS  Google Scholar 

  • Nader S, Bergen R, Sharp M, Arvin A (1995) Comparison of cell-mediated immunity (CMI) to varicella-zoster virus (VZV) in children and adults immunized with live attenuated varicella vaccine. J Infects Dis 171:13–17

    CAS  Google Scholar 

  • Naniche D, Varior-Krishnan G, Cernovi F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025–6032

    PubMed  CAS  Google Scholar 

  • Neff BJ, Weibel RE, Villarejos VM, Buynak EB, McLean AA, Morton DH, Wolanski BS, Hilleman MR (1981) Clinical and laboratory studies of KMcC strain live attenuated varicella virus (41071). Proc Soc Exp Biol Med 116:339–347

    Google Scholar 

  • Norrby E (1995) The paradigms of measles vaccinology. In: ter Meulen V, Billeter MA (eds) Measles virus. Springer. Berlin Heildelberg New York, pp 167–180 (Current topics in microbiology and immunology. vol 191 )

    Google Scholar 

  • Norrby E (1997) Human viral vaccines - yesterday, today and tomorrow. In: Brown F et al (eds) Vaccines 97. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 219–227

    Google Scholar 

  • Norrby E. Penttinen K (1978) Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live virus vaccines. J Infect Dis 138:672–676

    PubMed  CAS  Google Scholar 

  • Norrby E, Enders-Ruckle G, ter Meulen V (1975) Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis 132:262–269

    PubMed  CAS  Google Scholar 

  • O’Shea S, Best JM, Banatvala JE (1983) Viremia, virus excretion and antibody responses after challenge in volunteers with low levels of antibody of rubella virus. J Infect Dis 148:639–647

    PubMed  Google Scholar 

  • Odisseev H, Gacheva N (1994) Vaccinoprophylaxis of mumps using mumps vaccine. Strain Sofia 6, in Bulgaria. Vaccine 12:1251–1254

    PubMed  CAS  Google Scholar 

  • Palumbo P. Hoyt L, Demasio K, Oleske J, Connor E (1992) Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 11:1008–1014

    PubMed  CAS  Google Scholar 

  • Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K (1994) The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 231 (21):1397–1402

    Google Scholar 

  • Penttinen K, Cantell K, Somer P, Poikolainen A (1968) Mumps vaccination in the Finnish defense forces. Am J Epidemiol 88:234–244

    PubMed  CAS  Google Scholar 

  • Plotkin SA (1988) Rubella vaccine. In: Plotkin SA, Mortimer EA Jr (eds) Vaccines. Saunders, Philadelphia. pp 325–265

    Google Scholar 

  • Plotkin SA, Starr SE, Connor K, Morton D (1989) Zoster in normal children after varicella vaccine. J Infects Dis 159:1000–1001

    CAS  Google Scholar 

  • Radecke F, Billeter MA (1996) The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217:418–421

    PubMed  CAS  Google Scholar 

  • Robinson K, Mostrator A, Grencis RK (1995) Generation of rubella virus-neutralising antibodies by vaccination with synthetic peptides. FEMS Immunol Med Microbiol 10:191–198

    PubMed  CAS  Google Scholar 

  • Rota JS, Hummel KB, Rota PA, Bellini WJ (1992) Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188:135–142

    PubMed  CAS  Google Scholar 

  • Rota PA, Bloom AE, Vanchiere JA, Bellini WJ (1994) Evolution of the nucleoprotein and matrix genes of wild-types strains of measles virus. Virology 198:724–730

    PubMed  CAS  Google Scholar 

  • Sabin AB (1992) My last will and testament on rapid elimination and ultimate global eradication of poliomyelitis and measles. Paediatrics 90:162–169

    CAS  Google Scholar 

  • Schneider-Schaulies J, Schnorr JJ, Brinckman U, Dunster LM, Baczko K, Liebert UG, Schneider-Schaulies S, ter Meulen V (1995) Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci USA 92 (9):3943–3947

    PubMed  CAS  Google Scholar 

  • Seto NO, Gilliam S (1994) Expression and characterization of a soluble rubella virus E1 envelope protein. J Med Virol 44:192–199

    PubMed  CAS  Google Scholar 

  • Sharp M, Terada K, Wilson A, Nader S, Kinchington PE, Ruyechan WT, Hay J, Arvin AM (1992) Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J Infect Dis 165:852–858

    PubMed  CAS  Google Scholar 

  • Sheshberadaran H, Norrby E (1986) Characterization of epitopes on the measles virus hemagglutinin. Virology 152:58–65

    PubMed  CAS  Google Scholar 

  • Stratton KR, Howe CJ, Johnston RB Jr (eds) (1994) Adverse events associated with childhood vaccines: evidence bearing on causality. National Academy, Washington DC, pp 118–186

    Google Scholar 

  • Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288–1290

    PubMed  CAS  Google Scholar 

  • Taylor MJ, Godfrey E, Baczko K, ter Meulen V, Wild TF, Rima BK (1991) Identification of several defferent lineages of measles virus. J Gen Virol 72:83–88

    PubMed  CAS  Google Scholar 

  • Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK (1985) Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis 152:606–612

    PubMed  CAS  Google Scholar 

  • Tsolia M, Gershon A, Steinberg S, Gelb L (1990) Live attenuated varicella vaccine: evidence that the virus is attenuated and importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 116:184–189

    PubMed  CAS  Google Scholar 

  • Tyrell L, Norrby E (1978) The polypeptides of measles virus. J Gen Virol 39:219–229

    Google Scholar 

  • Vaheri A, Vesikari T, Oker-Blom N, Parkman PD, Veronelli J, Robbins TC (1972) Isolation of attenuated rubella-vaccine virus from human products of conception and uterine cervix. N Engl J Med 286:1071–1074

    PubMed  CAS  Google Scholar 

  • Valmari P, Lanning M, Tuokko H, Kouvalainen K (1987) Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy. Pediatr Infect Dis J 6:59–63

    PubMed  CAS  Google Scholar 

  • Varsanyi TM, Utter G, Norrby E (1984) Purification, morphology and antigenic characterization of measles virus envelope components. J Gen Virol 65:355–366

    PubMed  CAS  Google Scholar 

  • Varsanyi TM, Morein B Löve A, Norrby E (1987) Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol 61:3896–3901

    PubMed  CAS  Google Scholar 

  • Ward BJ, Griffin DE (1993) Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 67:171–177

    PubMed  CAS  Google Scholar 

  • Watson BM, Piercy SA, Plotkin SA, Starr SE (1993) Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 91:17–22

    PubMed  CAS  Google Scholar 

  • Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ (1996) Safety and immunogenicity of a combined measles, mumps, rubella and varicella vaccine (MMR(II)V) in healthy children. J Infect Dis 173:731–734

    PubMed  CAS  Google Scholar 

  • Weibel R, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Bunyak EB, Scolnick EM (1984) Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 310:1409–1415

    PubMed  CAS  Google Scholar 

  • Wharton M, Cochi SL, Hutcheson RH, Bistowish JM, Scaffner W (1988) A large outbreak of mumps in the postvaccine era. J Infect Dis 158:1253–1260

    PubMed  CAS  Google Scholar 

  • White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, Provost PJ, Ellis RW, Gerety RJ, Calandra GB (1991) Varicella vaccine (VARIVAX) in healthy children and adolescents: result from clinical trials 1987 to 1989. Pediatrics 87:604–610

    PubMed  CAS  Google Scholar 

  • Wild TF, Bernard A, Spehner D, Drillien R (1992) Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J Gen Virol 73:359–367

    PubMed  CAS  Google Scholar 

  • Wolinsky JS (1996) Rubella. In: Fields BN, Knipe PM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 899–929

    Google Scholar 

  • World Bank (1993) World development report 1993: investing in health. Oxford University Press, New York

    Google Scholar 

  • Zweiman B, Pappagianis D, Maibach H, Hildreth EA (1971) Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy Appl Immunol 40:834–841

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Norrby
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Wenner-Gren Institute Department of Immunology The Arrhenius Laboratories F5, Stockholm University, S-106 91, Stockholm, Sweden

    Peter Perlmann (Professor) (Professor)

  2. MTC, Karolinska Institute, S-171 77, Stockholm, Sweden

    Hans Wigzell (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Norrby, E. (1999). Vaccines Against Measles, Mumps, Rubella, and Varicella. In: Perlmann, P., Wigzell, H. (eds) Vaccines. Handbook of Experimental Pharmacology, vol 133. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59955-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59955-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64196-1

  • Online ISBN: 978-3-642-59955-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation